Hemomed

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Childhood cancers2 trials
• Melanoma2 trials
• Crohn's disease1 trial

Phase

• Phase 32 trials
• Phase 2/31 trial

Status

• Active, not recruiting3 trials

Lead sponsor

• Regeneron Pharmaceuticals2 trials
• Janssen Research & Development, LLC1 trial

Running trials

• Active, not recruiting

  A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

  NCT05608291· Phase 3· Regeneron Pharmaceuticals· Source

• Active, not recruiting

  Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma

  NCT05352672· Phase 3· Regeneron Pharmaceuticals· Source

• Active, not recruiting

  A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT03466411· Phase 2/3· Janssen Research & Development, LLC· Source